# Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

> **NCT01332409** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2000 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Salmeterol and Fluticasone

## Key facts

- **NCT ID:** NCT01332409
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-04
- **Final completion:** 2013-01
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332409, "Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01332409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*